CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
enamel matrix derivative (EMD) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04319770
NCT04319770N/ACompleted
CompareCT.gov

Effectiveness of Hyaluronic Acid Versus Enamel Matrix Derivatives in the Regeneration of Infrabony Defects. A Randomized Controlled Clinical Trial

University of Roma La Sapienza·interventional·Posted Mar 24, 2020·Updated Jun 4, 2020

In Brief

A clinical study evaluating enamel matrix derivative (EMD) and hyaluronic acid (HA) for Intrabony Periodontal Defect. Completed, enrolled 32 participants.

Detailed Summary

The purpose of this randomized controlled clinical trial (RCT) is to determine the efficacy hyaluronic acid (HA) versus enamel matrix derivatives (EMD) in the treatment of infrabony periodontal defects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntrabony Periodontal Defect
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 24, 2020
Enrollment StartSep 6, 2016
Primary CompletionOct 21, 2019
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.3 years ago

Interventions

enamel matrix derivative (EMD)device

periodontal regenerative surgery with enamel matrix derivative (EMD) (control)

hyaluronic acid (HA)device

periodontal regenerative surgery with hyaluronic acid (HA) (test)